RPG Life Sciences Limited (RPGLIFE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, RPG Life Sciences Limited (RPGLIFE) has a cash flow conversion efficiency ratio of 0.020x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs112.70 Million ≈ $1.22 Million USD) by net assets (Rs5.54 Billion ≈ $59.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See RPG Life Sciences Limited (RPGLIFE) liquidity interval to measure how many days the company can operate on defensive assets alone.
RPG Life Sciences Limited - Cash Flow Conversion Efficiency Trend (2005–2026)
This chart illustrates how RPG Life Sciences Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
RPG Life Sciences Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of RPG Life Sciences Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Lets Holding Group Co Ltd
SHE:002398
|
0.022x |
|
Entree Resources Ltd
TO:ETG
|
0.013x |
|
TARC Limited
NSE:TARC
|
0.245x |
|
Zhengzhou J and T Hi Tech Co
SHE:300845
|
0.021x |
|
Banco Santander Brasil SA
BA:BSBR
|
0.309x |
|
IOL Chemicals and Pharmaceuticals Limited
NSE:IOLCP
|
0.006x |
|
Build-A-Bear Workshop Inc
NYSE:BBW
|
0.156x |
|
Caleres Inc
NYSE:CAL
|
0.098x |
Annual Cash Flow Conversion Efficiency for RPG Life Sciences Limited (2005–2026)
The table below shows the annual cash flow conversion efficiency of RPG Life Sciences Limited from 2005 to 2026. For the full company profile with market capitalisation and key ratios, see RPGLIFE market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs6.05 Billion ≈ $65.47 Million |
Rs652.80 Million ≈ $7.06 Million |
0.108x | -26.52% |
| 2025-03-31 | Rs5.31 Billion ≈ $57.37 Million |
Rs778.60 Million ≈ $8.42 Million |
0.147x | -41.70% |
| 2024-03-31 | Rs3.75 Billion ≈ $40.54 Million |
Rs943.60 Million ≈ $10.20 Million |
0.252x | -14.74% |
| 2023-03-31 | Rs3.08 Billion ≈ $33.27 Million |
Rs908.20 Million ≈ $9.82 Million |
0.295x | +16.63% |
| 2022-03-31 | Rs2.56 Billion ≈ $27.66 Million |
Rs647.50 Million ≈ $7.00 Million |
0.253x | -5.96% |
| 2021-03-31 | Rs2.16 Billion ≈ $23.41 Million |
Rs582.70 Million ≈ $6.30 Million |
0.269x | -5.25% |
| 2020-03-31 | Rs1.77 Billion ≈ $19.10 Million |
Rs501.70 Million ≈ $5.43 Million |
0.284x | -0.38% |
| 2019-03-31 | Rs1.60 Billion ≈ $17.36 Million |
Rs457.80 Million ≈ $4.95 Million |
0.285x | +200.68% |
| 2018-03-31 | Rs1.55 Billion ≈ $16.74 Million |
Rs146.80 Million ≈ $1.59 Million |
0.095x | +93.85% |
| 2017-03-31 | Rs1.54 Billion ≈ $16.66 Million |
Rs75.40 Million ≈ $815.42K |
0.049x | -80.08% |
| 2016-03-31 | Rs1.34 Billion ≈ $14.45 Million |
Rs328.10 Million ≈ $3.55 Million |
0.246x | +1660.38% |
| 2015-03-31 | Rs1.25 Billion ≈ $13.54 Million |
Rs-19.70 Million ≈ $-213.05K |
-0.016x | +64.40% |
| 2014-03-31 | Rs1.26 Billion ≈ $13.60 Million |
Rs-55.60 Million ≈ $-601.29K |
-0.044x | -127.36% |
| 2013-03-31 | Rs762.30 Million ≈ $8.24 Million |
Rs123.20 Million ≈ $1.33 Million |
0.162x | -23.92% |
| 2012-03-31 | Rs741.40 Million ≈ $8.02 Million |
Rs157.50 Million ≈ $1.70 Million |
0.212x | +10.23% |
| 2011-03-31 | Rs748.31 Million ≈ $8.09 Million |
Rs144.21 Million ≈ $1.56 Million |
0.193x | -39.62% |
| 2010-03-31 | Rs644.31 Million ≈ $6.97 Million |
Rs205.66 Million ≈ $2.22 Million |
0.319x | -39.17% |
| 2009-03-31 | Rs549.21 Million ≈ $5.94 Million |
Rs288.19 Million ≈ $3.12 Million |
0.525x | -4.46% |
| 2008-03-31 | Rs492.02 Million ≈ $5.32 Million |
Rs270.23 Million ≈ $2.92 Million |
0.549x | +166.15% |
| 2007-03-31 | Rs742.36 Million ≈ $8.03 Million |
Rs153.19 Million ≈ $1.66 Million |
0.206x | +67.70% |
| 2006-03-31 | Rs667.72 Million ≈ $7.22 Million |
Rs82.17 Million ≈ $888.59K |
0.123x | -71.98% |
| 2005-03-31 | Rs150.60 Million ≈ $1.63 Million |
Rs66.13 Million ≈ $715.16K |
0.439x | -- |
About RPG Life Sciences Limited
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc. … Read more